Schedule 13D ownership disclosure

SYROS PHARMACEUTICALS, INC.

Security class unavailable · CUSIP: 87184Q107

Event date: 2016-07-06

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
20.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-16-645298
Form type
SC 13D
Filer
Flagship Ventures Fund IV General Partner LLC
CIK
CIK 1508051
Filed
Jul 11, 2016
Reporting period
Jul 06, 2016
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub